Clinical Trial Update: Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer [NA]

View source ↗

Summary

A clinical trial update notes a neoadjuvant regimen of Iparomlimab and Tuvonralimab plus chemotherapy before surgery for stage III non-small cell lung cancer; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tuvonralimab (tuvonralimab)
• iparomlimab

Snippet

Sponsor: Tang-Du Hospital | Conditions: Carcinoma, Non-Small-Cell Lung (NSCLC), Neoplasm Staging | NA | Status: NOT_YET_RECRUITING